Matricin

Matricin is a sesquiterpene lactone found in chamomile flowers that serves as the precursor to chamazulene, the blue compound responsible for many of chamomile's therapeutic effects. It primarily works through anti-inflammatory and anxiolytic mechanisms by modulating GABA neurotransmitter activity and inhibiting inflammatory mediators.

Origin & History

Matricin is a sesquiterpene lactone found primarily in Matricaria chamomilla L. (German chamomile), concentrated in the essential oil of the flower heads. It is extracted through steam distillation of dried flowers, during which process it converts to chamazulene, the compound responsible for chamomile's characteristic blue oil and anti-inflammatory properties.

Historical & Cultural Context

Matricaria chamomilla has extensive ethnomedicinal use for inflammation, pain, and gastrointestinal issues, with therapeutic applications documented from 1990-2016. While matricin-specific historical context is not detailed, it represents a key bioactive component in traditional chamomile preparations.

Health Benefits

• Anxiety reduction: RCT (n=57) showed significant reduction in Hamilton Anxiety Rating scores vs placebo (P=0.047) using chamomile extract containing matricin-derived compounds • Oral health improvement: Pilot RCT demonstrated 25.6% plaque reduction and 29.9% decrease in gingival bleeding with 1% chamomile extract mouthwash • PCOS symptom management: Meta-analysis of 4 RCTs (n=232) found heterogeneous improvements in clinical symptoms, though no significant effects on testosterone or lipids • Anti-inflammatory effects: Attributed to matricin's conversion to chamazulene, though specific mechanisms not detailed in available research • Sleep and migraine support: Referenced in reviews but lacking matricin-specific data or clinical evidence

How It Works

Matricin converts to chamazulene upon heating or distillation, which then inhibits cyclooxygenase and lipoxygenase enzymes to reduce inflammatory prostaglandins and leukotrienes. The compound also appears to enhance GABA neurotransmitter activity at benzodiazepine receptors, promoting anxiolytic effects. Additionally, matricin demonstrates antimicrobial properties by disrupting bacterial cell wall synthesis.

Scientific Research

Clinical evidence for isolated matricin is limited, with research focusing on chamomile extracts containing matricin as a component. A randomized controlled trial (PMID: 19593179) in 57 patients with generalized anxiety disorder showed significant anxiety reduction after 8 weeks. A pilot RCT (PMID: 28025442) demonstrated oral health benefits using chamomile mouthwash, while a meta-analysis of PCOS trials found mixed results across 232 patients.

Clinical Summary

A randomized controlled trial with 57 participants demonstrated significant anxiety reduction using chamomile extract containing matricin-derived compounds, with Hamilton Anxiety Rating scores showing statistically significant improvement versus placebo (P=0.047). A pilot RCT on oral health showed impressive results with 1% matricin-containing formulations producing 25.6% plaque reduction and 29.9% decrease in gingival bleeding. However, the clinical evidence base remains limited with small sample sizes, and more robust trials are needed to establish definitive therapeutic protocols.

Nutritional Profile

Matricin is a pure bioactive sesquiterpene lactone compound (C17H22O5, MW: 294.35 g/mol), not a whole food ingredient, therefore it carries no macronutrient (protein, carbohydrate, fat) or micronutrient (vitamin, mineral) profile in the conventional dietary sense. Key chemical characteristics: belongs to the guaianolide-type sesquiterpene lactone class; contains a bicyclic ring system with an α,β-unsaturated lactone moiety. Primary bioactive relevance: matricin is the biosynthetic precursor to chamazulene, the blue-pigmented anti-inflammatory compound formed during steam distillation of chamomile (Matricaria chamomilla); conversion occurs via thermal decarboxylation. Approximate concentrations in source material: matricin constitutes approximately 0.1–0.4% of dried chamomile flower heads by dry weight; in commercial chamomile essential oil, chamazulene (its derivative) typically represents 1–15% of oil composition depending on extraction conditions. Bioavailability notes: the α,β-unsaturated lactone group enables covalent binding to thiol groups in biological targets, facilitating anti-inflammatory activity via NF-κB pathway inhibition; oral bioavailability data for isolated matricin is limited, though chamomile matrix delivery shows measurable systemic absorption in human pharmacokinetic studies. No fiber, protein, or caloric content is applicable to this isolated compound.

Preparation & Dosage

No dosages for isolated matricin have been established. Chamomile extract studies used: 1000-1110 mg/day orally for 3 months (PCOS), unspecified oral dose for 8 weeks (anxiety), and 1% extract mouthwash for gingivitis. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Chamazulene, Apigenin-7-glucoside, Valerian root, L-theanine, Magnesium glycinate

Safety & Interactions

Matricin is generally well-tolerated with mild side effects including occasional drowsiness or gastrointestinal upset. Individuals allergic to plants in the Asteraceae family (ragweed, chrysanthemums, daisies) should avoid matricin-containing products due to potential cross-reactivity. The compound may enhance the effects of sedative medications and anticoagulants, requiring medical supervision for concurrent use. Pregnancy and breastfeeding safety data is insufficient, so use should be avoided during these periods.